Clinical trials recruiting for Hypercholesterolaemia
8
Recruiting trials
29
US states with sites
17
Countries
12%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 2 1Phase 3 2Phase 4 1Not applicable 3
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| CTX310 | 1 |
| Inclisiran | 1 |
| KJX839 | 1 |
| Laroprovstat | 1 |
| Laroprovstat/Rosuvastatin 1 | 1 |
| Laroprovstat/Rosuvastatin 2 | 1 |
| Praluent (Alirocumab) | 1 |
| Probiotic | 1 |
| QCZ484 | 1 |
| Rosuvastatin 1 | 1 |
| Rosuvastatin 2 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 3 |
| North Carolina | 3 |
| Alabama | 2 |
| Arizona | 2 |
| California | 2 |
| Georgia | 2 |
| Illinois | 2 |
| Kansas | 2 |
| Louisiana | 2 |
| Maryland | 2 |
| New York | 2 |
| Oregon | 2 |
Top cities
Jacksonville, Florida 3Chicago, Illinois 2Durham, North Carolina 2Houston, Texas 2Miami Lakes, Florida 2Port Orange, Florida 2Portland, Oregon 2Richmond, Virginia 2Anderson, South Carolina 1Annapolis, Maryland 1
Self-screener
Recruiting trials
- A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
- A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- An Efficacy and Safety Study of Akkermansia Muciniphila AKM Lab-01 in Hypercholesterolaemia
- Arizona CEAL: Linking Social Care With Healthcare Systems to Address SDOH
- Evaluation of Adherence, Persistence and Efficacy of Treatment With Alirocumab 300mg in Italy
- LATAM LOWERS LDL-C
- Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days
Related conditions
Trials recruiting for Hypercholesterolaemia often also study these conditions. Each links to its own recruiting-trial list.
High cholesterol 103Hypertension 1201Social Determinants of Health (SDOH) 4Mixed Dyslipidemia 4Metabolic Disease 28Lipid Disorder 5Hypertriglyceridemia 5Homozygous Familial Hypercholesterolemia (HoFH) 4Heterozygous Familial Hypercholesterolemia (HeFH) 5Dyslipidemias 22
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Hypercholesterolaemia trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.